Conversion Surgery in Metastatic Gastric Cancer and Cancer Dormancy as a Prognostic Biomarker

Cancers - Switzerland
doi 10.3390/cancers12010086
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Identification of F5 as a Prognostic Biomarker in Patients With Gastric Cancer

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2020English

Finding a New Prognostic Biomarker for Metastatic Colorectal Cancer

Journal of the Korean Society of Coloproctology
2012English

Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

MDM2 Is a Useful Prognostic Biomarker for Resectable Gastric Cancer

Cancer Science
Cancer ResearchMedicineOncology
2013English

Disseminated Tumour Cells as a Prognostic Biomarker in Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2011English

Prognostic Value of Bone Scan Index as an Imaging Biomarker in Metastatic Prostate Cancer: A Meta-Analysis

Oncotarget
Oncology
2017English

Plasma microRNA Profiles: Identification of miR-1229-3p as a Novel Chemoresistant and Prognostic Biomarker in Gastric Cancer

Scientific Reports
Multidisciplinary
2020English

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer

Journal of Cancer
Oncology
2017English

In Vitro Models of Breast Cancer Metastatic Dormancy

Frontiers in Cell and Developmental Biology
Developmental BiologyCell Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy